Inventors:
Robert Kania - San Diego CA, US
Steven Bender - Oceanside CA, US
Allen Borchardt - San Diego CA, US
Stephan Cripps - San Diego CA, US
Ye Hua - La Jolla CA, US
Michael Johnson - San Diego CA, US
Theodore Johnson - San Diego CA, US
Hiep Luu - San Diego CA, US
Cynthia Palmer - San Diego CA, US
Siegfried Reich - Solana Beach CA, US
Min Teng - San Diego CA, US
Christine Thomas - West Borough MA, US
Michael Varney - Solana Beach CA, US
Michael Wallace - San Diego CA, US
Michael Collins - San Diego CA, US
International Classification:
C07D471/02, A61K031/4745, A61K031/4162
US Classification:
514/303000, 514/406000, 546/119000, 548/361100
Abstract:
Indazole compounds that modulate and/or inhibit the activity of certain protein kinases are described. These compounds and pharmaceutical compositions containing them are capable of mediating tyrosine kinase signal transduction and thereby modulate and/or inhibit unwanted cell proliferation. The invention is also directed to the therapeutic or prophylactic use of pharmaceutical compositions containing such compounds, and to methods of treating cancer and other disease states associated with unwanted angiogenesis and/or cellular proliferation, such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, and psoriasis, by administering effective amounts of such compounds.